Search research articles
Contact Us
Filters
Showing results (511-520 of 625) with videos related to
Page
of 63
Sort By:
Annals of the Rheumatic Diseases
|
April 8, 2018
2018 update of the EULAR recommendations for the management of Behçet's syndrome
Gulen Hatemi, Robin Christensen, Dongsik Bang, et al.
Journal of Autoimmunity
|
April 22, 2018
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
Arsene Mekinian, Mathieu Resche-Rigon, Cloé Comarmond, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Clinical and Experimental Rheumatology
|
December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia
Giulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Seminars in Arthritis and Rheumatism
|
June 30, 2018
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome
Pietro Leccese, Yesim Ozguler, Robin Christensen, et al.
Rheumatology (Oxford, England)
|
August 15, 2018
Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations
Yesim Ozguler, Pietro Leccese, Robin Christensen, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 27, 2026
Machine learning, whole genome sequencing, and Mendelian randomization support a role of CRP on COVID-19 severity
Francesca Lantieri, Stefania Croci, Sergio Decherchi, et al.
Journal of Clinical Immunology
|
June 15, 2025
NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients
Sara Signa, Martina Bartolucci, Martina Bonacini, et al.
Annals of the Rheumatic Diseases
|
October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
Rosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Annals of the Rheumatic Diseases
|
July 5, 2019
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Agueda, Sara Monti, et al.
Page
of 63
Search research articles
Search
Showing results (511-520 of 625) with videos related to
Sort By:
Page
of 63
Annals of the Rheumatic Diseases
|
April 8, 2018
2018 update of the EULAR recommendations for the management of Behçet's syndrome
Gulen Hatemi, Robin Christensen, Dongsik Bang, et al.
Journal of Autoimmunity
|
April 22, 2018
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
Arsene Mekinian, Mathieu Resche-Rigon, Cloé Comarmond, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Clinical and Experimental Rheumatology
|
December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia
Giulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Seminars in Arthritis and Rheumatism
|
June 30, 2018
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome
Pietro Leccese, Yesim Ozguler, Robin Christensen, et al.
Rheumatology (Oxford, England)
|
August 15, 2018
Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations
Yesim Ozguler, Pietro Leccese, Robin Christensen, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 27, 2026
Machine learning, whole genome sequencing, and Mendelian randomization support a role of CRP on COVID-19 severity
Francesca Lantieri, Stefania Croci, Sergio Decherchi, et al.
Journal of Clinical Immunology
|
June 15, 2025
NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients
Sara Signa, Martina Bartolucci, Martina Bonacini, et al.
Annals of the Rheumatic Diseases
|
October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
Rosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Annals of the Rheumatic Diseases
|
July 5, 2019
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Agueda, Sara Monti, et al.
Page
of 63